|
Sep 30
|
15 Best Dividend Stocks for Lifelong Passive Income
|
|
Sep 29
|
Is AbbVie Inc.'s (NYSE:ABBV) ROE Of 78% Impressive?
|
|
Sep 27
|
15 Unhealthiest Countries in Latin America
|
|
Sep 27
|
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
|
Sep 27
|
AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
|
|
Sep 27
|
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
|
|
Sep 27
|
Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
|
|
Sep 27
|
AbbVie’s acquired Parkinson’s disease drug shines in Phase III trial
|
|
Sep 26
|
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
|
|
Sep 26
|
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
|
|
Sep 12
|
FDA Grants Label Expansion to J&J's Tremfya in Ulcerative Colitis
|
|
Sep 11
|
Why Analysts Are Bullish on AbbVie Inc. (ABBV)
|
|
Sep 11
|
AbbVie's Serena Williams Migraine Ad Criticized by FDA as 'Misleading'
|
|
Sep 11
|
Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
|
|
Sep 11
|
The Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian
|
|
Sep 10
|
Top Stock Reports for Visa, AbbVie & Anheuser-Busch
|
|
Sep 10
|
Health Canada Approves AbbVie's CONSTELLA® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients 6 to 17 Years of Age
|
|
Sep 9
|
Why AbbVie (ABBV) Outpaced the Stock Market Today
|
|
Sep 9
|
3 Things You Need to Know if You Buy AbbVie Stock Today
|
|
Sep 9
|
AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs
|